COSMO Pharmaceuticals SA (0RGI) — Tangible Net Worth Ratio
COSMO Pharmaceuticals SA (0RGI) has a Tangible Net Worth Ratio of 43.7% as of June 2026. This metric is calculated by deducting intangible assets (£323.04 Million) from net assets (£573.73 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore COSMO Pharmaceuticals SA equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
COSMO Pharmaceuticals SA Tangible Net Worth Ratio (2005–2025)
This chart shows how COSMO Pharmaceuticals SA's Tangible Net Worth Ratio has changed across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 43.7%, reflecting net assets of £573.73 Million with intangible assets of £323.04 Million GBP. For live market cap and overall valuation, see 0RGI company net worth.
Annual Tangible Net Worth Ratio for COSMO Pharmaceuticals SA (2005–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for COSMO Pharmaceuticals SA from 2005 to 2025, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore how much does COSMO Pharmaceuticals SA reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (GBP) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.4% | £488.80 Million | £325.63 Million | £612.16 Million | ▼ -34.6 pp |
| 2024 | 68.0% | £505.09 Million | £161.66 Million | £646.77 Million | ▲ +50.9 pp |
| 2023 | 17.1% | £429.04 Million | £355.62 Million | £553.98 Million | ▼ -5.1 pp |
| 2022 | 22.2% | £463.79 Million | £360.88 Million | £759.59 Million | ▼ -5.8 pp |
| 2021 | 28.0% | £512.68 Million | £369.31 Million | £805.56 Million | ▼ -71.2 pp |
| 2020 | 99.2% | £400.12 Million | £3.24 Million | £596.16 Million | ▲ +4.7 pp |
| 2019 | 94.5% | £393.73 Million | £21.67 Million | £585.16 Million | ▼ -2.4 pp |
| 2018 | 96.9% | £444.85 Million | £13.96 Million | £625.69 Million | ▼ -0.2 pp |
| 2017 | 97.1% | £470.12 Million | £13.82 Million | £497.97 Million | ▲ +0.4 pp |
| 2016 | 96.7% | £415.56 Million | £13.78 Million | £443.47 Million | ▼ -2.2 pp |
| 2015 | 98.9% | £403.65 Million | £4.50 Million | £437.94 Million | ▲ +2.0 pp |
| 2014 | 96.9% | £152.29 Million | £4.70 Million | £225.62 Million | ▼ -0.8 pp |
| 2013 | 97.7% | £220.16 Million | £5.14 Million | £243.00 Million | ▲ +2.0 pp |
| 2012 | 95.7% | £150.41 Million | £6.45 Million | £183.30 Million | ▲ +30.3 pp |
| 2011 | 65.4% | £63.43 Million | £21.97 Million | £78.04 Million | ▲ +0.3 pp |
| 2010 | 65.1% | £58.37 Million | £20.39 Million | £91.83 Million | ▼ -14.8 pp |
| 2009 | 79.9% | £59.80 Million | £12.04 Million | £71.46 Million | ▼ -4.3 pp |
| 2008 | 84.1% | £43.24 Million | £6.86 Million | £57.77 Million | ▼ -6.8 pp |
| 2007 | 91.0% | £35.15 Million | £3.17 Million | £47.23 Million | ▲ +54.3 pp |
| 2006 | 36.7% | £5.34 Million | £3.38 Million | £23.61 Million | ▲ +83.7 pp |
| 2005 | -47.1% | £631.00K | £928.00K | £28.21 Million | — |